While the HSP-associated mutation presented here demonstrates a novel gain-of-function disease mechanism in ATL1, a recent study characterized two gain-of-function mutations in ATL3 (Y192C and P338R) that had been identified in hereditary sensory neuropathy patients (38, 39, 60). This evidence concerns the gene ATL1 and hereditary sensory and autonomic neuropathy.